| 摘要 |
The invention relates, in general, to new formulations and dosage units containing glimepiride of defined particle size and/or salts thereof that are useful for the therapeutic treatment (including prophylactic treatment) of mammals, including humans, without the need for micronizing any excipients together with the glimepiride that advantageously saves time, energy and resources and a process for making the same. In particular, the invention can be useful for the treatment of diabetes.
|
